231 related articles for article (PubMed ID: 26044099)
1. A unique story in neonatal research: the development of a porcine surfactant.
Curstedt T; Halliday HL; Speer CP
Neonatology; 2015; 107(4):321-9. PubMed ID: 26044099
[TBL] [Abstract][Full Text] [Related]
2. Surfactants: past, present and future.
Halliday HL
J Perinatol; 2008 May; 28 Suppl 1(Suppl 1):S47-56. PubMed ID: 18446178
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
[TBL] [Abstract][Full Text] [Related]
4. Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome.
Speer CP; Gefeller O; Groneck P; Laufkötter E; Roll C; Hanssler L; Harms K; Herting E; Boenisch H; Windeler J
Arch Dis Child Fetal Neonatal Ed; 1995 Jan; 72(1):F8-13. PubMed ID: 7743295
[TBL] [Abstract][Full Text] [Related]
5. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
Pfister RH; Soll RF; Wiswell T
Cochrane Database Syst Rev; 2007 Oct; (4):CD006069. PubMed ID: 17943881
[TBL] [Abstract][Full Text] [Related]
6. Choosing a right surfactant for respiratory distress syndrome treatment.
Ramanathan R
Neonatology; 2009; 95(1):1-5. PubMed ID: 18832858
[TBL] [Abstract][Full Text] [Related]
7. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
Pfister RH; Soll RF; Wiswell T
Cochrane Database Syst Rev; 2007 Jul; (3):CD006069. PubMed ID: 17636826
[TBL] [Abstract][Full Text] [Related]
8. History of surfactant from 1980.
Halliday HL
Biol Neonate; 2005; 87(4):317-22. PubMed ID: 15985754
[TBL] [Abstract][Full Text] [Related]
9. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
[TBL] [Abstract][Full Text] [Related]
10. Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future.
Sardesai S; Biniwale M; Wertheimer F; Garingo A; Ramanathan R
Pediatr Res; 2017 Jan; 81(1-2):240-248. PubMed ID: 27706130
[TBL] [Abstract][Full Text] [Related]
11. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.
Wiseman LR; Bryson HM
Drugs; 1994 Sep; 48(3):386-403. PubMed ID: 7527760
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.
Choukroun ML; Llanas B; Apere H; Fayon M; Galperine RI; Guenard H; Demarquez JL
Pediatr Pulmonol; 1994 Nov; 18(5):273-8. PubMed ID: 7898964
[TBL] [Abstract][Full Text] [Related]
13. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
[TBL] [Abstract][Full Text] [Related]
14. Cerebral and lung effects of a new generation synthetic surfactant with SP-B and SP-C analogs in preterm lambs.
Rey-Santano C; Mielgo VE; Murgia X; Gomez-Solaetxe MA; Salomone F; Bianco F; Pelizzi N; Loureiro B; López de Heredia Y Goya J
Pediatr Pulmonol; 2017 Jul; 52(7):929-938. PubMed ID: 28221717
[TBL] [Abstract][Full Text] [Related]
15. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
[TBL] [Abstract][Full Text] [Related]
17. Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Members of the Collaborative European Multicenter Study Group.
Herting E; Gefeller O; Land M; van Sonderen L; Harms K; Robertson B
Pediatrics; 2000 Nov; 106(5):957-64; discussion 1135. PubMed ID: 11061760
[TBL] [Abstract][Full Text] [Related]
18. Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
Pfister RH; Soll R; Wiswell TE
Cochrane Database Syst Rev; 2009 Oct; (4):CD006180. PubMed ID: 19821357
[TBL] [Abstract][Full Text] [Related]
19. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
[TBL] [Abstract][Full Text] [Related]
20. Overview of clinical trials comparing natural and synthetic surfactants.
Halliday HL
Biol Neonate; 1995; 67 Suppl 1():32-47. PubMed ID: 7647157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]